Prediction of Vulnerable Plaque Using Coronary CT Angiography and Computational Fluid Dynamic in Acute Coronary Syndrome
PVCFD
1 other identifier
observational
200
0 countries
N/A
Brief Summary
The aim of the PVCFD trial is to predict vulnerable plaque confirmed by OCT using coronary CT angiography and computational fluid dynamics in patients with acute coronary syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2020
CompletedFirst Posted
Study publicly available on registry
August 24, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedAugust 24, 2020
August 1, 2020
2 years
August 19, 2020
August 19, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
The difference of area under curve among the three prediction models
from 1 to 72 hours
The difference of net reclassification index (NRI) and integrated discrimination improvement (IDI) among the three prediction models
from 1 to 72 hours
Secondary Outcomes (3)
The percentage in APC (low-attenuation plaque, positive remodeling, napkin-ring sign, and spotty calcification) between the vulnerable plaque group and stable plaque group
from 1 to 72 hours
The difference in hemodynamic parameters (FFRCT,ΔFFRCT, WSS and PWS) between the vulnerable plaque group and stable plaque group
from 1 to 72 hours
The optimal cut-off values of hemodynamic parameters (FFRCT,ΔFFRCT, WSS and PWS) to identify vulnerable plaque
from 1 to 72 hours
Study Arms (2)
Group A(vulnerable plaque group)
Lipid plaques with fibrous cap thickness less than 65um, erosion and coronary artery dissection detected by OCT are defined as vulnerable plaque.
Group B(stable plaque group)
Lipid plaques with fibrous cap thickness more than 65um detected by OCT are defined as vulnerable plaque.
Eligibility Criteria
patients with acute coronary syndrome
You may qualify if:
- )acute coronary syndrome was diagnosed according to universal definition of ACS; and 2) coronary CTA was completed before CAG; and 3) definitely culprit lesion can be recognized by CAG; 4) OCT was done to detect coronary atherosclerotic plaques confirmed by CAG.
You may not qualify if:
- \) Previous history stent implantation; 2) previous history of coronary artery bypass graft surgery; 3) ACS without clear culprit lesion; 4) poor image quality of coronary CTA for APC and CFD analysis; 5) myocardial infarction secondary to other reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, pHD, Director of Cardiovascular Department
Study Record Dates
First Submitted
August 19, 2020
First Posted
August 24, 2020
Study Start
September 1, 2020
Primary Completion
September 1, 2022
Study Completion
December 1, 2022
Last Updated
August 24, 2020
Record last verified: 2020-08